Your browser doesn't support javascript.
loading
Emerging challenges in understanding trypanosome antigenic variation.
McCulloch, Richard; Cobbold, Christina A; Figueiredo, Luisa; Jackson, Andrew; Morrison, Liam J; Mugnier, Monica R; Papavasiliou, Nina; Schnaufer, Achim; Matthews, Keith.
Afiliação
  • McCulloch R; The Wellcome Centre for Molecular Parasitology, University of Glasgow, 120 University Place, Glasgow, G12 8TA, U.K. Richard.mcculloch@glasgow.ac.uk.
  • Cobbold CA; School of Mathematics and Statistics, University of Glasgow, University Place, Glasgow, G12 8QS,United Kingdom. Christina.Cobbold@glasgow.ac.uk.
  • Figueiredo L; Instituto de Medicina Molecular, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal. lmf@medicina.ulisboa.pt.
  • Jackson A; Institute of Infection and Global Health, Department of Infection Biology, University of Liverpool, 146 Brownlow Hill, Liverpool, L3 5RF, United Kingdom. a.p.jackson@liv.ac.uk.
  • Morrison LJ; The Roslin Institute, Royal (Dick) School of Veterinary Studies, Division of Infection and Immunity, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, United Kingdom. liam.morrison@roslin.ed.ac.uk.
  • Mugnier MR; Department of Molecular Microbiology & Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. mmugnie1@jhu.edu.
  • Papavasiliou N; Immune Diversity (D150), Division Immunology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germany. n.papavasiliou@dkfz-heidelberg.de.
  • Schnaufer A; Institute for Immunology & Infection Research, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, Charlotte Auerbach Road, Edinburgh, EH9 3FL, United Kingdom. keith.matthews@ed.ac.uk; achim.schnaufer@ed.ac.uk.
  • Matthews K; Immune Diversity (D150), Division Immunology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germany. n.papavasiliou@dkfz-heidelberg.de.
Emerg Top Life Sci ; 1(6): 585-592, 2017 Dec 22.
Article em En | MEDLINE | ID: mdl-30271884
ABSTRACT
Many pathogens evade host immunity by periodically changing the proteins they express on their surface - a phenomenon termed antigenic variation. An extreme form of antigenic variation, based around switching the composition of a Variant Surface Glycoprotein (VSG) coat, is exhibited by the African trypanosome Trypanosoma brucei, which causes human disease. The molecular details of VSG switching in T. brucei have been extensively studied over the last three decades, revealing in increasing detail the machinery and mechanisms by which VSG expression is controlled and altered. However, several key components of the models of T. brucei antigenic variation that have emerged have been challenged through recent discoveries. These discoveries include new appreciation of the importance of gene mosaics in generating huge levels of new VSG variants, the contributions of parasite development and body compartmentation in the host to the infection dynamics and, finally, potential differences in the strategies of antigenic variation and host infection used by the crucial livestock trypanosomes T. congolense and T. vivax. This review will discuss all these observations, which raise questions regarding how secure the existing models of trypanosome antigenic variation are. In addition, we will discuss the importance of continued mathematical modelling to understand the purpose of this widespread immune survival process.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Emerg Top Life Sci Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Emerg Top Life Sci Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM